Dublin, Nov. 20, 2020 (GLOBE NEWSWIRE) -- The "Direct-to-Consumer Genetic Testing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering.
The scope of this report includes DTC genetic testing technologies, applications, industry subsegments, major strategic alliances, patents, and companies. The market sizes for next-generation cancer diagnostics are given for 2019, 2020 (estimated) and 2025 (forecasted).
This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and genotyping microarrays.
The report then discusses several of the significant large-scale population sequencing initiatives that are contributing to DTC genetic testing development. Key forces driving the market are enumerated.
The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2019 through September 2020. Industry subsectors analyzed include ancestry, clinical health, recreational health, sequencing data-based blockchain, sequencing instrument, long-read sequencing, sequencing informatics, and PCR.
The market for DTC genetic testing is analyzed in depth. The market is analyzed by test purpose (ancestry, health, lifestyle); technology platform (PCR, genotyping arrays, sequencing); by delivery format (test kits, virtual tests); and by geography (North America, Europe, Asia/Pacific, RoW).
Direct-to-consumer (DTC) genetic testing involves the analysis and interpretation of a person's genome. A consumer can access DTC genetic testing from a commercial company or from a health care provider.
DTC genetic testing has evolved in the past 10 years. Initially, it focused on personal applications outside traditional health care, such as exploring ancestry, and has trended toward interfacing with clinical care in non-traditional ways, such as partnerships between DTC companies with health systems.
Analysis of a customer's genome helps to know about their ancestry inference, disease risks, and other personal traits. Based on this, the main applications include ancestry, health, and lifestyle.
Several factors are driving growth in the DTC genetic testing industry, including a shifting emphasis on health-related applications, the rise of personalized genomics, and increasing convenience of ordering goods and services from virtual at-home settings. This latter trend has been accelerated by the COVID-19 pandemic.
There is rising public awareness of DNA and its impact on health and genetic disorders, ancestry, and lifestyle. These trends are having a favorable impact on the at-home genetic testing market. This report provides an in-depth analysis of the DTC genetic testing industry
12 data tables and 39 additional tables
An overview of the global markets and technologies for direct to consumer (DTC) genetic testing
Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
Information on key genomic regions associated with genetic testing and description of instruments and technologies used for DTC genetic testing
Coverage of DNA sequencing; microarray; and software industries and description of the key initiatives in the genetic testing industry
Detailed analysis of the current market trends, market forecast, and discussion of technological, regulatory, and competitive elements as well as economic trends affecting the future marketplace for direct to consumer (DTC) genetic testing and impact analysis of COVID-19 on the market
Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
Profiles of the key companies in the DTC testing industry, including Chendu 23Mofang Biotechnology Co. Ltd (23Mofand), Genetic Technologies Ltd, Illumina Inc., Myriad Genetics Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Inc.
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Chapter 2 Summary and Highlights Overview
Chapter 3 Overview
Large-Scale Initiatives and Consortia
Chapter 4 DTC Genetic Technologies
Introduction to Nucleic Acid Technologies
Genetic Variation and Analysis
DTC Testing Platforms
Next-generation Sequencing Technology
Polymerase Chain Reaction (PCR) Technology
Genome-wide Association Studies
Polygenic Risk Scoring
Genomic Data in the Biopharma Context
Chapter 5 DTC Genetic Testing Industry
DTC Ancestry Genetic Testing Industry
Health-Focused DTC Genetic Testing Industry: Two Market Models
DTC Clinical Health Genetic Testing Industry
DTC Recreational Health Genetic Testing Industry
Sequencing Data-based Blockchain Industry
Sequencing Instruments Industry
Long-Read Sequencing Industry
Sequencing Informatics Industry
Chapter 6 Industry Acquisitions and Strategic Alliances
Acquisitions and Strategic Alliances
Chapter 7 DTC Genetic Testing Markets
DTC Market Driving Forces
Consumer Marketing Efforts
Rare Disease Initiatives
Increasing Focus on Healthcare Applications
Technical Advances in Testing Platforms
DTC Genetic Testing Market
DTC Genetic Testing Ancestry Market
Health DTC Genetic Testing Market
Lifestyle DTC Genetic Testing Market
DTC Genetic Testing Market by Geography
Chapter 8 Patents
SNP-related DTC Patents
23andMe Patent Analysis
Chapter 9 Company Profiles
Anglia Dna Services
Berry Genomics Co. Ltd.
Centrillion Genomics Technologies
Chengdu 23Mofang Biotechnology Co. Ltd
Color Genomics Inc.
DNA Diagnostics Center Inc.
DNA Nudge, Ltd
Eone-Diagnomics Genome Center
Fulgent Genetics Inc.
Full Genomes Corp. Inc.
Gene By Gene Ltd.
Genesis Healthcare Co.
Genetic Technologies Ltd.
Grey Genetics Llc.
Helix Opco Llc
Labogenomics Co. Ltd.
Laboratory Corp. Of America Inc.
Medigoo Oy Inc.
Myriad Genetics Inc.
Oxford Nanopore Technologies Ltd.
Pathway Genomics Corp.
Pwn Health Llc
Quest Diagnostics Inc.
Theragen Etex Inc.
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/62hajf
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900